PTX3 and hepatocellular carcinoma: The work of Deng et al. [72], in which the described research was carried out on a group of over 500 participants, showed that the concentrations of Pentraxin 3 in patients with HCC were higher compared with patients with chronic hepatitis or cirrhosis.